How PX1 Tests Every PT-141 Lot (HPLC, MS, Endotoxin)
In preclinical research, experimental reproducibility depends entirely on the molecular purity and analytical integrity of trial reagents. Every lot of PT-141 synthesized for PX1 Research undergoes a comprehensive, multi-stage analytical protocol—utilizing RP-HPLC, ESI-MS, LAL endotoxin quantification, and fill-sterility verification—to ensure strict compliance with rigorous laboratory standards.
Quick answer
In preclinical research, experimental reproducibility depends entirely on the molecular purity and analytical integrity of trial reagents. Every lot of PT-141 synthesized for PX1 Research undergoes a comprehensive, multi-stage analytical protocol—utilizing RP-HPLC, ESI-MS, LAL endotoxin quantification, and fill-sterility verification—to ensure strict compliance with rigorous laboratory standards.
Key takeaways
- [PT-141](/research-peptides/pt-141) (Bremelanotide) is a synthetic cyclic heptapeptide and a potent melanocortin receptor agonist.
- Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) serves as the primary analytical tool for determining the chemical purity and chromatographic homogeneity of synthetic peptides.
- While RP-HPLC establishes the relative purity percentage of a sample, Mass Spectrometry is required to confirm exact molecular identity.
- A common point of ambiguity in laboratory peptide procurement is the distinction between gross lyophilized cake weight and actual Net Peptide Content (NPC).
Analytical Rigor for PT-141 in Preclinical Research
PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide and a potent melanocortin receptor agonist. Derived structurally from the alpha-melanocyte-stimulating hormone (α-MSH) peptide family, PT-141 has been extensively investigated for melanocortin-receptor signaling linked to sexual-health pathways in animal models and cellular assays. Because melanocortin receptors (specifically MC3R and MC4R) exhibit high sensitivity to structural variations and micro-impurities, utilizing a pt-141 third party tested compound is critical for producing valid, unconfounded empirical data.
To eliminate batch-to-batch variation, PX1 Research subjects every production run of PT-141 to an exhaustive battery of analytical assays prior to repository placement. Rather than relying on supplier self-certifications or representative testing, our protocol mandates independent verification of every individual lot by ISO 17025 accredited analytical laboratories. Researchers accessing our research library hub can examine full methodological standards applicable to our entire catalog.
Step 1: Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC)
Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) serves as the primary analytical tool for determining the chemical purity and chromatographic homogeneity of synthetic peptides. For PT-141, the stationary phase typically utilizes a C18 silica-based column, while the mobile phase employs a gradient system composed of acetonitrile and water acidified with 0.1% trifluoroacetic acid (TFA).
During HPLC analysis, UV detection at 214 nm (the absorption wavelength of peptide bonds) monitors the eluting species. Purity is calculated via peak area percent integration. PX1 Research enforces a strict purity threshold: every lot of PT-141 10mg must demonstrate an area purity exceeding 98.0%. This analytical stringency guarantees that truncated sequences, baseline noise, deletion peptides, and chemical modifications (such as deamidation or oxidation) are identified and excluded prior to distribution.
Step 2: Electrospray Ionization Mass Spectrometry (ESI-MS)
While RP-HPLC establishes the relative purity percentage of a sample, Mass Spectrometry is required to confirm exact molecular identity. Electrospray Ionization Mass Spectrometry (ESI-MS) or LC-MS/MS is performed on every batch to measure the exact mass-to-charge ratio (m/z) of the ionized PT-141 molecule.
PT-141 has a theoretical monoisotopic molecular weight of approximately 1024.18 Da (chemical formula: C50H68N14O10). ESI-MS spectrum analysis confirms that the primary mass peak aligns perfectly with this theoretical value within an analytical tolerance of ±0.5 Da. This step rules out misidentified sequences, incorrect cyclic disulfide configurations, and improper amino acid substitutions, ensuring structural accuracy for target receptor binding assays.
Step 3: Net Peptide Content Quantification and Nitrogen Analysis
A common point of ambiguity in laboratory peptide procurement is the distinction between gross lyophilized cake weight and actual Net Peptide Content (NPC). Lyophilized peptide preparations inherently retain a proportion of counter-ions (such as acetate or TFA salts) and bound residual moisture. Consequently, a 10 mg vial containing raw lyophilized powder does not consist of 10 mg of pure active peptide monomer.
PX1 Research conducts elemental nitrogen analysis (Dumas method) or quantitative amino acid analysis (AAA) to establish the precise Net Peptide Content of each lot. By determining the exact ratio of peptide weight to total mass, researchers can calculate accurate molar concentrations for in vitro assays without guessing hydration states or salt fractions. This exactness is fundamental when configuring quantitative dose-response curves in preclinical study models.
Step 4: Limulus Amebocyte Lysate (LAL) Endotoxin Testing
Bacterial endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—are potent pyrogens that interfere with cellular pathways, trigger non-specific inflammatory cascades, and skew receptor signaling data in cell cultures and animal models. Ensuring low endotoxin levels is vital for maintaining culture viability and objective experimental metrics.
Every batch of pt-141 third party tested peptide undergoes quantitative endotoxin screening via the chromogenic Limulus Amebocyte Lysate (LAL) assay. PX1 Research enforces an endotoxin standard of <0.05 EU/mg. This low endotoxin threshold guarantees that observed cellular responses are attributable solely to PT-141 melanocortin receptor activation, rather than background endotoxin-mediated immune responses.
Step 5: Aseptic Processing, Sterility, and Fill Volume Verification
Following synthesis, purification, and lyophilization, PT-141 is aliquoted into borosilicate glass vials within an ISO Class 5 cleanroom environment. To confirm that the fill process maintains product integrity, sample vials from the beginning, middle, and end of each filling run undergo bioburden and sterility testing.
Sterility verification protocols adhere to modified USP <71> standards, utilizing membrane filtration or direct inoculation into Fluid Thioglycollate Medium (FTM) and Soybean-Casein Digest Medium (SCDM). Samples are incubated over a 14-day observation window to confirm the absence of aerobic bacteria, anaerobic bacteria, and fungal contaminants. In addition, gravimetric fill checks ensure that every vial meets strict target mass specifications within tight tolerances.
Step 6: Retained Sample Archives and Stability Monitoring
PX1 Quality Assurance mandates that a specific percentage of vials from every manufactured PT-141 lot be set aside in climate-controlled, long-term stability storage (-20°C and -80°C archives). These retained samples serve two operational purposes:
First, they allow immediate re-testing should an investigator report anomalous experimental outcomes or require secondary analytical confirmation. Second, retained vials are subjected to periodic stability testing over 12, 24, and 36 months to track peptide degradation kinetics, moisture absorption, and purity retention over extended periods. This continuous monitoring confirms that our storage and cold-chain packaging protocols effectively preserve molecular stability.
How to Match Your PT-141 Vial Lot Number to the COA
Transparency requires that analytical data be directly traceable to the physical product in the researcher's laboratory. Every vial of PT-141 shipped by PX1 features a high-density, tamper-evident label containing a unique Lot Number, Expiration Date, and Direct Specification Code.
To verify your sample, researchers can navigate directly to our dedicated certificate of analysis lookup portal. By entering the lot code printed on the vial label, you can immediately download the complete third-party analytical package—including raw HPLC chromatograms, mass spectrum plots, net peptide content fractions, and LAL endotoxin test results. This lot-specific verification workflow guarantees that the data sheet matches the exact physical material on your laboratory bench.
Comparative Analysis: PT-141 within the Melanocortin Peptide Class
When designing preclinical trials targeting melanocortin receptor pathways, investigators frequently compare PT-141 against structurally related synthetic analogues. A clear understanding of analytical differences across this peptide class helps researchers select the appropriate ligand for their specific experimental model.
For example, PT-141 is a metabolite derivative of Melanotan II, lacking the lipophilic C-terminal amide structure that drives non-selective melanocyte stimulation. While Melanotan II demonstrates broad affinity across MC1R, MC3R, MC4R, and MC5R, PT-141 exhibits a selective affinity profile favorizing MC3R and MC4R central nervous system signaling pathways. Similarly, synthetic research analogues like Bremelanotide variations require distinct HPLC gradient profiles during quality control due to minor alterations in sequence cyclization and hydrophobic interaction parameters.
Laboratory Reconstitution and Solution Handling Protocol
Lyophilized PT-141 is shipped in a stable, desiccated state, but maintaining peptide integrity post-receipt requires strict adherence to proper laboratory reconstitution protocols. Reconstitution should always be conducted in an ISO 5 laminar flow hood using sterile, non-pyrogenic diluents such as bacteriostatic water (0.9% benzyl alcohol) or sterile phosphate-buffered saline (PBS, pH 7.4).
To calculate exact solvent volumes and target molar concentrations for in vitro assays, researchers can utilize our interactive reconstitution calculator. Avoid vigorous vortexing during solubilization, as high mechanical shear stress can disrupt peptide tertiary structure or cause aggregation. Once dissolved, aliquots should be stored at -20°C or -80°C to prevent hydrolysis. Explore our full catalog of research peptides for complementary reagents, or contact our sales team regarding wholesale lab account provisioning for high-throughput screening projects.
Frequently Asked Questions
Why is PT-141 third-party tested by individual lot rather than annually?
Peptide synthesis, purification, and lyophilization carry inherent lot-to-lot variations. Testing every individual production lot ensures that parameters like HPLC purity, mass identity, and endotoxin levels are confirmed for the exact vial used in your experiment, eliminating batch variation risks.
What RP-HPLC purity threshold does PX1 mandate for PT-141?
PX1 Research mandates that every lot of PT-141 achieve a chromatographic purity of >98.0% area percent by RP-HPLC prior to batch release.
How does Mass Spectrometry confirm the identity of PT-141?
Electrospray Ionization Mass Spectrometry (ESI-MS) measures the mass-to-charge ratio of the peptide. PX1 verifies that the observed mass peak matches PT-141's theoretical monoisotopic mass (~1024.18 Da) within ±0.5 Da.
What is the endotoxin limit for PX1 PT-141 lots?
PX1 enforces an endotoxin threshold of <0.05 EU/mg via the quantitative LAL assay, ensuring the material is free of pyrogenic lipopolysaccharides that could interfere with cellular or preclinical assays.
How do I match my vial of PT-141 to its specific COA?
Locate the lot number printed on your vial label, visit our COA lookup page at /coa, and enter the lot number to download the full HPLC, MS, and endotoxin testing report for that specific batch.
What is the difference between total lyophilized cake weight and net peptide content?
Lyophilized cakes contain active peptide, residual moisture, and counter-ions (such as acetate or TFA). Net Peptide Content quantifies the actual weight of the pure peptide component, allowing accurate molar calculations.
How should lyophilized PT-141 be stored upon receipt?
Lyophilized PT-141 should be stored in a freezer at -20°C or -80°C away from light. Upon reconstitution, avoid repeated freeze-thaw cycles by storing the solution in single-use aliquots at low temperatures.
Are PX1 research peptides intended for human consumption?
No. All products supplied by PX1 Research, including PT-141, are strictly for laboratory research, in vitro assays, and preclinical research use only. They are never for human, clinical, or veterinary administration.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.